Fi3 FINANCIAL ADVISORS LLC Boosts Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Key Points

• Fi3 Financial Advisors LLC boosted its stake in Johnson & Johnson by 71.6%, holding 4,680 shares worth approximately $776,000 as of the latest SEC filing.
• Johnson & Johnson reported $2.77 earnings per share for the last quarter, beating estimates of $2.68, and had revenue of $23.74 billion, surpassing analyst expectations.
• The company declared a quarterly dividend of $1.30 per share, representing an annual yield of 3.0%, with a dividend payout ratio of 55.61%.

Fi3 FINANCIAL ADVISORS LLC lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 71.6% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,680 shares of the company's stock after buying an additional 1,952 shares during the period. Fi3 FINANCIAL ADVISORS LLC's holdings in Johnson & Johnson were worth $776,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of the business. Elios Financial Group Inc. increased its stake in shares of Johnson & Johnson by 1.5% in the first quarter. Elios Financial Group Inc. now owns 4,496 shares of the company's stock valued at $746,000 after buying an additional 66 shares during the period. Atlantic Family Wealth LLC lifted its holdings in shares of Johnson & Johnson by 4.4% during the first quarter. Atlantic Family Wealth LLC now owns 1,603 shares of the company's stock worth $266,000 after purchasing an additional 67 shares during the period. MBA Advisors LLC grew its stake in shares of Johnson & Johnson by 1.2% in the first quarter. MBA Advisors LLC now owns 5,553 shares of the company's stock worth $921,000 after purchasing an additional 68 shares during the last quarter. Sovereign Financial Group Inc. raised its position in Johnson & Johnson by 1.8% during the 1st quarter. Sovereign Financial Group Inc. now owns 3,928 shares of the company's stock worth $651,000 after purchasing an additional 69 shares during the last quarter. Finally, Nabity Jensen Investment Management Inc lifted its holdings in Johnson & Johnson by 1.5% during the 1st quarter. Nabity Jensen Investment Management Inc now owns 4,624 shares of the company's stock worth $767,000 after buying an additional 69 shares during the period. 69.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on JNJ shares. Wall Street Zen lowered Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a research note on Friday, July 18th. Sanford C. Bernstein reaffirmed a "market perform" rating on shares of Johnson & Johnson in a research note on Wednesday, April 16th. The Goldman Sachs Group raised shares of Johnson & Johnson from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $157.00 to $172.00 in a research note on Wednesday, April 9th. Raymond James Financial decreased their price target on Johnson & Johnson from $165.00 to $162.00 and set an "outperform" rating for the company in a report on Monday, April 14th. Finally, Piper Sandler reissued an "overweight" rating on shares of Johnson & Johnson in a research note on Thursday, July 17th. Nine research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Johnson & Johnson presently has a consensus rating of "Moderate Buy" and a consensus target price of $174.50.

Johnson & Johnson Stock Down 0.0%

Shares of Johnson & Johnson stock traded down $0.02 on Wednesday, hitting $170.72. The company had a trading volume of 8,955,892 shares, compared to its average volume of 9,226,614. The stock has a market capitalization of $411.14 billion, a price-to-earnings ratio of 18.26, a P/E/G ratio of 2.17 and a beta of 0.41. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.76 and a current ratio of 1.01. Johnson & Johnson has a 1 year low of $140.68 and a 1 year high of $172.18. The stock has a 50 day moving average of $158.17 and a 200-day moving average of $157.00.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings data on Wednesday, July 16th. The company reported $2.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.68 by $0.09. The firm had revenue of $23.74 billion for the quarter, compared to the consensus estimate of $22.85 billion. Johnson & Johnson had a net margin of 25.00% and a return on equity of 32.49%. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.82 EPS. As a group, sell-side analysts forecast that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 26th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, August 26th. Johnson & Johnson's dividend payout ratio is 55.61%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.